Patrick W. Pace

Dr. Pace has served on Encision’s board of directors since April 2012, serving as chairman from August 2013 through August 2015. Pat is also a Director on UTIMCO’s Private Markets team, helping manage the endowments’ private markets portfolio. He is also responsible for healthcare investments across the endowments. He joined UTIMCO after serving as an Advisor to EDG Partners, a healthcare private equity firm. Previously, Pat served as Managing Director at Citadel Investment Group and helped launch its effort in investment banking. Prior to Citadel, he led healthcare high yield and distressed debt investing as part of AIG Investments, served as a Senior Analyst covering the medical device industry at UBS, and worked in Equities at Credit Suisse First Boston. Dr. Pace also serves on the board of MMIS, Inc, and as Executive Chairman of Nanospectra Biosciences, a medical device company focusing on the use of nanoparticles in the treatment of a variety of diseases, where he recently led a recapitalization of the company and a change in strategic focus. Dr. Pace began his career as a resident in Otolaryngology (ENT) at the University of Virginia Hospital. He holds a Bachelor of Arts, with Honors in Psychology, from Vanderbilt University and a Doctor of Medicine from The University of Texas Medical School at Houston.